DANIEL J STARKS
CIK 902132 · Chairman, CEO & President · last filed 2026-04-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$770.60M
Companies
3
Total Filings
85
Lifetime Open-Market Net
-$171.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABT | Director | 6,751,361 | $114.14 | $770.60M | -$25.67M | 21 | 2026-04-28 |
| ST JUDE MEDICAL, LLC (STJ) Delisted | Chairman, CEO & President | 6,319,888 | — | — | -$145.50M | 58 | 2016-12-20 |
| UROLOGIX INC (ULGX) Delisted | Director | 30,000 | — | — | $0 | 2 | 2008-11-13 |
Recent Filings · Page 8 of 9
85 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-09-15 | ST JUDE MEDICAL, LLC (STJ) Delisted | Mixed | — | -$4.74M | EDGAR |
| 2008-08-01 | ST JUDE MEDICAL, LLC (STJ) Delisted | Mixed | — | -$8.38M | EDGAR |
| 2008-07-22 | ST JUDE MEDICAL, LLC (STJ) Delisted | Mixed | — | -$5.09M | EDGAR |
| 2008-05-02 | ST JUDE MEDICAL, LLC (STJ) Delisted | Sell (S) | −65,500 | -$2.90M | EDGAR |
| 2008-05-02 | ST JUDE MEDICAL, LLC (STJ) Delisted | Mixed | +65,900 | -$183.0K | EDGAR |
| 2008-04-22 | ST JUDE MEDICAL, LLC (STJ) Delisted | Sell (S) | −50,500 | -$2.28M | EDGAR |
| 2008-04-22 | ST JUDE MEDICAL, LLC (STJ) Delisted | Mixed | +50,500 | -$2.51M | EDGAR |
| 2007-12-12 | ST JUDE MEDICAL, LLC (STJ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-11-08 | UROLOGIX INC (ULGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-09-14 | ST JUDE MEDICAL, LLC (STJ) Delisted | Sell (S) | −30,900 | -$1.45M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.